| Basics |
TherapeuticsMD, Inc.
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
|
| IPO Date: |
October 31, 2011 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$13.54M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 3.21%
|
| Avg Daily Range (30 D): |
$0.03 | 2.37%
|
| Avg Daily Range (90 D): |
$0.03 | 2.50%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.22M |
| Avg Daily Volume (30 D): |
.28M |
| Avg Daily Volume (90 D): |
.11M |
| Trade Size |
| Avg Trade Size (Sh.): |
288 |
| Avg Trade Size (Sh.) (30 D): |
213 |
| Avg Trade Size (Sh.) (90 D): |
206 |
| Institutional Trades |
| Total Inst.Trades: |
1,122 |
| Avg Inst. Trade: |
$1.43M |
| Avg Inst. Trade (30 D): |
$2.37M |
| Avg Inst. Trade (90 D): |
$2.37M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.56M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
10.79K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$.05
|
$-.06
|
$.02
|
|
Diluted EPS
|
$.05
|
$-.06
|
$.02
|
|
Revenue
|
$ .95M
|
$ .39M
|
$ .67M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ .55M
|
$ -.65M
|
$ .25M
|
|
Operating Income / Loss
|
$ -.7M
|
$ -.87M
|
$ -.32M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ .32M
|
$ .69M
|
$ .01M
|
|
PE Ratio
|
26.20
|
|
|
| Splits |
|
May 09, 2022:
1:50
|
|
Oct 03, 2011:
1:100
|
|
Jul 27, 2009:
3:1
|
|
|
|
